GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke
JP Bassand, PN Apenteng, D Atar, AJ Camm… - Future …, 2021 - Taylor & Francis
The Global Anticoagulant Registry in the Field-Atrial Fibrillation (GARFIELD-AF) examined
real-world practice in a total of 57,149 (5069 retrospective, 52,080 prospective) patients with …
real-world practice in a total of 57,149 (5069 retrospective, 52,080 prospective) patients with …
Clinical effectiveness of direct oral anticoagulants vs warfarin in older patients with atrial fibrillation and ischemic stroke: findings from the patient-centered research …
Y Xian, H Xu, EC O'Brien, S Shah, L Thomas… - JAMA …, 2019 - jamanetwork.com
Importance Current guidelines recommend direct oral anticoagulants (DOACs) over warfarin
for stroke prevention in patients with atrial fibrillation (AF) who are at high risk. Despite …
for stroke prevention in patients with atrial fibrillation (AF) who are at high risk. Despite …
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 …
S Haas, JA Camm, D Harald, J Steffel… - Clinical Research in …, 2023 - Springer
Abstract Background The G lobal A nticoagulant R egistry in the FIELD–A trial F ibrillation
(GARFIELD-AF) is a worldwide non-interventional study of stroke prevention in patients with …
(GARFIELD-AF) is a worldwide non-interventional study of stroke prevention in patients with …
Healthcare resource utilization in patients with newly diagnosed atrial fibrillation: a global analysis from the GARFIELD-AF registry
LG Mantovani, P Cozzolino, P Ferrara, S Virdone… - Healthcare, 2023 - mdpi.com
The management of atrial fibrillation (AF), the most common sustained arrhythmia, impacts
healthcare resource utilization (HCRU). This study aims to estimate global resource use in …
healthcare resource utilization (HCRU). This study aims to estimate global resource use in …
Cost-effectiveness of left atrial appendage occlusion during cardiac surgery in France: An economic evaluation based on the LAAOS III study
M Benmalek, M Connock, L Savio, JF Obadia… - Plos one, 2024 - journals.plos.org
Objectives Left atrial appendage occlusion during cardiac surgery is a therapeutic option for
stroke prevention in patients with atrial fibrillation. The effectiveness and safety of left atrial …
stroke prevention in patients with atrial fibrillation. The effectiveness and safety of left atrial …
Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term vitamin K …
EK Choi, YS Lee, AKC Chern, P Jiampo… - Open …, 2020 - openheart.bmj.com
Background and purpose Real-world data about treatment convenience and satisfaction in
Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K …
Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K …
Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical …
B Falissard, F Picard, I Mahe, O Hanon, E Touze… - Archives of …, 2019 - Elsevier
Background Non-vitamin K antagonist oral anticoagulants (NOACs), including apixaban, are
recommended for prevention of stroke and systemic embolism in non-valvular atrial …
recommended for prevention of stroke and systemic embolism in non-valvular atrial …
[HTML][HTML] Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry
H Deng, A Shantsila, P Guo, TS Potpara, X Zhan… - Archives of …, 2019 - Elsevier
Background Female sex has been linked with worse prognosis in patients with atrial
fibrillation (AF). Clinical risk stratification of women with AF may help decision-making before …
fibrillation (AF). Clinical risk stratification of women with AF may help decision-making before …
[HTML][HTML] Eligibility for extended antithrombotic therapy for secondary prevention of acute coronary syndrome
D Faria, M Santos, SB Baptista, J Ferreira… - Revista Portuguesa de …, 2020 - Elsevier
Abstract Introduction and Objectives Recent randomized controlled trials have evaluated the
benefit of extended antithrombotic therapy in secondary prevention of acute coronary …
benefit of extended antithrombotic therapy in secondary prevention of acute coronary …
Recomendaciones de expertos en la mejora de la prevención efectiva del ictus isquémico en la fibrilación auricular no valvular: papel del rivaroxabán
AIP Cabeza, JN Portero, MR Ortiz, LT Sánchez… - Revista Española de …, 2020 - Elsevier
La fibrilación auricular aumenta de manera marcada el riesgo de ictus isquémico. A pesar
de que los antagonistas de la vitamina K (AVK) reducen ese riesgo, tienen una eficacia …
de que los antagonistas de la vitamina K (AVK) reducen ese riesgo, tienen una eficacia …